ProMetic Life Sciences Inc. (PLI.TO: Quote) said Tuesday that it received a $4.6 million purchase order from Octapharma under the onging supply agreement between ProMetric and Octapharma.
Octapharma is a Swiss based, independent global plasma fractionation company that specializes in human proteins.
Shipments to Octapharma in relation to this order are expected to exceed $2.0 million during the second half of 2012.
Click here to receive FREE breaking news email alerts for ProMetic Life Sciences Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org